KR830001957A - 베타-락탐화합물의 할로겐화 반응물 제조방법 - Google Patents

베타-락탐화합물의 할로겐화 반응물 제조방법 Download PDF

Info

Publication number
KR830001957A
KR830001957A KR1019800000398A KR800000398A KR830001957A KR 830001957 A KR830001957 A KR 830001957A KR 1019800000398 A KR1019800000398 A KR 1019800000398A KR 800000398 A KR800000398 A KR 800000398A KR 830001957 A KR830001957 A KR 830001957A
Authority
KR
South Korea
Prior art keywords
formula
alkyl
structural formula
compound
group
Prior art date
Application number
KR1019800000398A
Other languages
English (en)
Other versions
KR830001892B1 (ko
Inventor
로우웰·델로스·하트필드
크리스 브라스즈크작 라리
퓌셔 잭·웨인
Original Assignee
아서 알·훼일
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21732838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR830001957(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 아서 알·훼일, 일라이 릴리 앤드 캄파니 filed Critical 아서 알·훼일
Publication of KR830001957A publication Critical patent/KR830001957A/ko
Application granted granted Critical
Publication of KR830001892B1 publication Critical patent/KR830001892B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L24/00—Arrangements for connecting or disconnecting semiconductor or solid-state bodies; Methods or apparatus related thereto
    • H01L24/74—Apparatus for manufacturing arrangements for connecting or disconnecting semiconductor or solid-state bodies
    • H01L24/78—Apparatus for connecting with wire connectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2224/00—Indexing scheme for arrangements for connecting or disconnecting semiconductor or solid-state bodies and methods related thereto as covered by H01L24/00
    • H01L2224/74—Apparatus for manufacturing arrangements for connecting or disconnecting semiconductor or solid-state bodies and for methods related thereto
    • H01L2224/78—Apparatus for connecting with wire connectors
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
    • H01L2924/0001—Technical content checked by a classifier
    • H01L2924/00014—Technical content checked by a classifier the subject-matter covered by the group, the symbol of which is combined with the symbol of this group, being disclosed without further technical details
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Computer Hardware Design (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Power Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

베타-락탐화합물의 할로겐화 반응물 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 구조식(Ⅱ)의 화합물을 구조식(Ⅴ)의 아인산트리아릴과 염소 또는 브롬과를 거의 무수비활성 유기용매(Substantiall anhdrous inert organic slovent)중에 당량비로 가하여 얻은반응통제 화합물(kinetically controlled product)인 구조식(Ⅳ)의 할로겐화 화합물을 -30℃이하의 거의 무수비활성 유기용매 내에서 약 1.0 내지 약 1.3 당량비로 반응시켜 구조식(Ⅰ)의 화합물을 제조하는 방법.
    상기 구조식에서
    X는 C1 또는 Br,
    Z는 수소, 할로, C1-C4알킬, 또는 C1-C4알콕시(Alkoxy)
    R는 카르복실산 보호기,
    R5는
    (1) 수소, C1-C4알킬, 또는 할로 (C1-C4알킬),
    (2) R6: 페일 또는 불소, 염소, 브롬 및 요드원자, 니트로, 시아노, C1-C4알킬, C1-C4알콕시, 보호하이드록시, 카바밀, 트리플루오로메틸 및 메탄설폰아미도로 구성된 군중 1개 내지 2개기로 치환된 페닐기.
    (3) 화학식 R6(O)mCH2 -인 화학기, 단 m은 1 또는 0, R6는 (2)의 정의와 동일.
    (4) 화학식 R6aCH2 -인 화학기, 단 R6a는사이크로헥사디에닐, 2-푸릴, 2-티에닐, 또는 3-티에닐, 또는
    (5) R가 상기 정의와 동일한 화학식 COOR기이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019800000398A 1979-02-01 1980-02-01 베타 락탐 화합물의 할로겐화 제조 방법 KR830001892B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8647 1979-02-01
US06/008,647 US4226986A (en) 1979-02-01 1979-02-01 Process for halogenation of β-lactam compounds

Publications (2)

Publication Number Publication Date
KR830001957A true KR830001957A (ko) 1983-05-19
KR830001892B1 KR830001892B1 (ko) 1983-09-17

Family

ID=21732838

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019800000398A KR830001892B1 (ko) 1979-02-01 1980-02-01 베타 락탐 화합물의 할로겐화 제조 방법
KR1019800000400A KR830001906B1 (ko) 1979-02-01 1980-02-01 β-락탐 화합물의 할로겐화 반응물 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019800000400A KR830001906B1 (ko) 1979-02-01 1980-02-01 β-락탐 화합물의 할로겐화 반응물 제조방법

Country Status (22)

Country Link
US (1) US4226986A (ko)
EP (1) EP0014566B1 (ko)
JP (1) JPS55104289A (ko)
KR (2) KR830001892B1 (ko)
BE (1) BE881426A (ko)
BG (1) BG35896A3 (ko)
CA (1) CA1150725A (ko)
CH (1) CH642971A5 (ko)
CS (1) CS275604B6 (ko)
DE (1) DE3063395D1 (ko)
ES (2) ES488234A0 (ko)
FR (1) FR2447926A1 (ko)
GB (1) GB2041374B (ko)
HU (1) HU182065B (ko)
IE (1) IE49503B1 (ko)
IL (1) IL59266A (ko)
IT (1) IT1130240B (ko)
LU (1) LU82121A1 (ko)
MX (1) MX6576E (ko)
PH (2) PH14774A (ko)
RO (1) RO84256B (ko)
ZM (1) ZM1280A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1148938A (en) * 1979-05-08 1983-06-28 John R. Corfield Preparation of cephalosporins and intermediates employed therein
US4281117A (en) * 1980-09-04 1981-07-28 Eli Lilly And Company Process for 3-chloro cephalosporin nucleus
IN181695B (ko) * 1992-08-10 1998-09-05 Ranbaxy Lab Ltd
US5604222A (en) * 1993-12-27 1997-02-18 Lupin Laboratories, Ltd. Method for the preparation of 2-chloro sulfinyl azetidinones
US5578721A (en) * 1994-07-11 1996-11-26 Lupin Laboratories Limited Process for preparation of 3-exomethylene cepham sulfoxide esters
JP6669831B2 (ja) * 2018-10-02 2020-03-18 株式会社ユニバーサルエンターテインメント 遊技機

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
US3962227A (en) * 1973-02-23 1976-06-08 Eli Lilly And Company 3-halo cephalosporins
GB1472869A (en) * 1975-08-11 1977-05-11 Farmaceutici Italia Intermediates for cephalosporin synthesis
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
GB1576219A (en) * 1976-12-31 1980-10-01 Connlab Holdings Ltd Thiazoleneazetidinone derivatives

Also Published As

Publication number Publication date
KR830001955A (ko) 1983-05-21
CH642971A5 (fr) 1984-05-15
IL59266A (en) 1983-05-15
PH14774A (en) 1981-12-09
FR2447926B1 (ko) 1982-12-31
ES8104302A1 (es) 1981-04-16
BG35896A3 (en) 1984-07-16
ES495102A0 (es) 1981-08-16
BE881426A (fr) 1980-07-30
CS275604B6 (en) 1992-03-18
IT1130240B (it) 1986-06-11
RO84256B (ro) 1984-07-30
GB2041374B (en) 1983-04-13
ES488234A0 (es) 1981-04-16
MX6576E (es) 1985-07-24
LU82121A1 (fr) 1980-04-23
JPS55104289A (en) 1980-08-09
EP0014566B1 (en) 1983-05-25
US4226986A (en) 1980-10-07
JPH0115515B2 (ko) 1989-03-17
DE3063395D1 (en) 1983-07-07
RO84256A (ro) 1984-05-23
IE49503B1 (en) 1985-10-16
ES8106530A1 (es) 1981-08-16
CS8000660A2 (en) 1991-03-12
PH17758A (en) 1984-11-27
EP0014566A1 (en) 1980-08-20
ZM1280A1 (en) 1980-09-22
KR830001906B1 (ko) 1983-09-19
GB2041374A (en) 1980-09-10
KR830001892B1 (ko) 1983-09-17
IL59266A0 (en) 1980-05-30
IT8019610A0 (it) 1980-01-31
CA1150725A (en) 1983-07-26
IE800187L (en) 1980-08-01
HU182065B (en) 1983-12-28
FR2447926A1 (fr) 1980-08-29

Similar Documents

Publication Publication Date Title
KR910000657A (ko) 옥사-또는 티아-졸린 유도체
KR830001957A (ko) 베타-락탐화합물의 할로겐화 반응물 제조방법
KR830007662A (ko) 5,6,7,7a-테트라하이드로-4H-티에노 [3,2-c]-피리딘-2-온 유도체의 제조방법
ES8206519A1 (es) Procedimiento para la preparacion de nuevos benzoxazoles y benzotiazoles
KR840006487A (ko) 세팔로스포린의 제조방법
GB1388394A (en) Substituted cinnamanilides and biocidal uses thereof
KR840000172A (ko) 살균용과 생장조절용 조성물 및 그 제조
KR850005838A (ko) 1,3,2-디옥사보리난의 제조방법
KR850006188A (ko) 스피로-3-헤테로-아졸리딘디온의 제조방법
KR830001969A (ko) 할로겐화 화합물의 안정화 방법
US4264774A (en) 2-Thiophenesulfonyl bromides
KR830001943A (ko) 페니실린과 세팔로스포린 이미노할라이드의 제조방법
KR920002545A (ko) 살균제
FI814214L (fi) Foerfarande foer framstaellning av furanfoereningen
KR830006234A (ko) 5-치환된 디알루르산의 제조방법
KR860000295A (ko) 옥시캄 유도체의 제조방법
KR830007639A (ko) 락탐 화합물의 제조방법
GB951479A (en) Preparation of tetracyanoethylene
US2802834A (en) 3-tetrahydrofurfuryloxyphthalide
KR830002766A (ko) 옥사졸리노 아제티디논의 제조방법
JPS55108838A (en) Preparation of arkyl-1-chloro-2-oxocycloalkane carboxylate
Mulford et al. gem-Dinitro Esters. V. The Alcoholysis and Hydrolysis of 3, 3-Dinitropropionitriles1
KR830001895A (ko) 피리딜이미노 메틸벤젠 유도체의 제조방법
GB970121A (en) Organic phosphorothioate derivatives
KR830005159A (ko) 살균제 티오글리클산 아닐리드와 그의 제조방법 및 동물질을 함유하는 살충조성물